Further, we also verified that the expression of GRID2, PADI4, RIPK2, CUL4B, BCL6, MRPS31, GPI, and MAP 2 K1 were both significantly increased, and levels of MAPK, ELAVL1, RAB14, KLF9, ARF1, ARFGAP1, ATG7, ABCA7, SFT2D2, E2F2, MAPK7, and UHRF1 were both significantly decreased in PD. This evidence concerns the gene ARFGAP1 and Parkinson disease.